JDJia-Xi Duan

Jia-Xi Duan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia-Xi Duan has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Chen-Yu Zhang

    Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China

    9 shared publications
  • Wen-Jing Zhong

    Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China

    8 shared publications
  • Yu-Biao Liu

    Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China

    8 shared publications
  • Yong Zhou

    Department of Physiology, School of Basic Medicine Science, Central South University, Changsha, China

    6 shared publications
  • Cha-Xiang Guan

    Central South University

    5 shared publications
  • Nan-Shi-Yu Yang

    Department of Physiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China

    5 shared publications

Latest Publications

  • Open Access

    PDHA1 Hyperactivation‐Mediated Glucose Metabolism Reprogramming Fuels Neutrophil NETosis and Promotes Acute Lung Injury

    by Yu‐Biao Liu, Wen‐Jing Zhong, Chen‐Yu Zhang, Meng‐Rui Chen, Nan‐Shi‐Yu Yang, Han‐Xi Sha, Yan‐Ling Qiu, Hui Chen, Jin‐Tong Yang, Li‐Ying Liang, et al.

    Neutrophil extracellular trap (NET) formation, termed NETosis, is a key driver of lung tissue injury in acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the precise mechanisms that trigger neutrophil NETosis remain incompletely understood. Here, we observed that neutrophils from both ALI mice and ARDS patients exhibited NETosis alongside a pronounced selective metabolic shift, characterized by enhanced oxidative phosphorylation (OXPHOS) and attenuated glycolytic activity. Phosphoproteomic profiling revealed that this shift was driven by aberrant activation of pyruvate dehydrogenase E1 subunit alpha (PDHA1), resulting from its dephosphorylation at Ser293. Inhibiting PDHA1 activity, using either the inhibitor 3‐fluoropyruvate (3‐FP) or genetic knockdown, effectively reversed this selective metabolic reprogramming and suppressed NETosis. We further constructed neutrophil‐targeted 3‐FP‐loaded albumin nanoparticles (3‐FP‐BSA NPs). These nanoparticles were specifically taken up by activated neutrophils, markedly inhibited NETosis, and alleviated lipopolysaccharide‐induced ALI in mice. Mechanistically, RNA‐seq revealed the enrichment of the AMPK in neutrophils during NETosis. AMPK phosphorylated PDHA1 at Ser314, which disrupted the PDHA1‐pyruvate dehydrogenase kinase 1 (PDK1) interaction and inhibited PDHA1 phosphorylation at Ser293. Ultimately, PDHA1 hyperactivation‐driven selective metabolic reprogramming precipitated mitochondrial stress and mtROS accumulation, thereby initiating NETosis. This study defines a targetable metabolic pathway in neutrophils and advances a specific PDHA1‐nanotherapeutic strategy against ALI/ARDS.

  • Open Access

    NINJ1 plays a vital role in the release of neutrophil extracellular traps during acute lung injury

    by Wen-Jing Zhong, Yu-Biao Liu, Xin-Yu Yang, Meng-Rui Chen, Nan-Shi-Yu Yang, Chen-Yu Zhang, Jian-Bing Xiong, Wei-Feng Tang, Cha-Xiang Guan, Yan-Feng Zhang, et al.

    Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NET release in neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NET release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that K45 and N60 are critical for NINJ1 oligomerization and subsequent NET release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NET release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.


  • Correction to: Spil mediated sEH overexpression contributes to the senescence of alveolar epithelial cells during pulmonary fibrosis in mice

    by Chen-Yu Zhang, Wen-Jing Zhong, Jin-Tong Yang, Yan-Ling Qiu, Han-Xi Sha, An-Jun Ou, Yu-Biao Liu, Xiao-Ting Huang, Yong Zhou, Jia-Xi Duan, et al.

  • Open Access

    Fibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice

    by Xin-Xin Guan, Wen-Jing Zhong, Wei-Feng Tang, Yu-Biao Liu, Meng-Rui Chen, Jun-Lan Li, Chen-Yu Zhang, Yong Zhou, Cha-Xiang Guan, Jing-Ni Wu, et al.

    Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggests that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro, Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.


  • Open Access

    NINJ1 plays a vital role in the release of neutrophil extracellular traps in acute lung injury

    by Yong Zhou, Wen-Jing Zhong, Yu-Biao Liu, Xin-Yu Yang, Meng-Rui Chen, Nan-Shi-Yu Yang, Chen-Yu Zhang, Jian-Bing Xiong, Wei-Feng Tang, Cha-Xiang Guan, et al.

    Excessive neutrophil extracellular traps (NETs) formation is a significant contributor to acute lung injury (ALI), making its inhibition a novel therapeutic avenue to improve outcomes. In this study, we revealed that a novel pore-forming protein ninjurin-1 (NINJ1) was predominantly highly expressed in pro-inflammatory neutrophil subpopulations during ALI, using public single-cell RNA sequencing and hotspot analysis. Furthermore, we demonstrated that the NINJ1 oligomerization was essential for the NETs release of neutrophils from both acute respiratory distress syndrome (ARDS) patients and ALI mice. Genetic ablation of Ninj1 in neutrophils abolished NETs release, thereby attenuating pulmonary dysfunction and reducing ALI-related lethality. Mechanistically, we found that N-glycosylation of NINJ1 at the 60 site was the major contributor to its oligomerization and NETs release. In summary, our findings reveal a novel pore-forming protein-mediated mechanism for NETs release and highlight NINJ1 as a potential therapeutic target for the treatment of ALI/ARDS.

  • Spil-mediated sEH overexpression contributes to the senescence of alveolar epithelial cells during pulmonary fibrosis in mice

    by Chen-Yu Zhang, Wen-Jing Zhong, Jin-Tong Yang, Yan-Ling Qiu, Han-Xi Sha, An-Jun Ou, Yu-Biao Liu, Xiao-Ting Huang, Yong Zhou, Jia-Xi Duan, et al.

    Alveolar epithelial cell (AEC) senescence is a crucial driver of pulmonary fibrosis (PF). Epoxyeicosatrienoic acids (EETs) are synthesized from arachidonic


  • Open Access

    PDHA1 Hyperactivation Orchestrates Metabolic Reprogramming Promoting Endothelial Senescence

    by Wen-Jing Zhong, Nan-Shi-Yu Yang, Chen-Yu Zhang, Yu-Biao Liu, Ling Jin, An-Jun Ou, Hui Chen, Juan Li, Yong Zhou, Bai-Mei He, et al.

    While recent studies have established links between metabolic reprogramming and inflammatory senescence, the specific metabolic drivers in vascular aging remain incompletely defined. Here, we systematically characterized senescent phenotypes and targeted metabolomic profiles in primary aging endothelial cells, identifying a pyruvate dehydrogenase E1 component subunit alpha (PDHA1)-dependent metabolic shift as a hallmark of cellular senescence. Using a D-galactose-induced senescence model, we demonstrated that endothelial-specific Pdha1 knockdown alleviated pulmonary vascular endothelial senescence and associated functional decline. Further investigation revealed that PDHA1 hyperactivation disrupts mitochondrial homeostasis, leading to excessive mitochondrial reactive oxygen species production, oxidative mitochondrial DNA damage, and subsequent cytosolic mitochondrial DNA release, thereby triggering cyclic GMP-AMP synthase-mediated senescence. Mechanistically, decreased lactylation of PDHA1 at lysine 336 potentiated its activity and promoted dephosphorylation at serine 293. This posttranslational cross talk enhanced PDHA1 activation and drove a prosenescent metabolic shift. Together, our results elucidate that a previously unrecognized PDHA1 hyperactivation promotes endothelial senescence.

  • Open Access

    Fibroblast growth factor-inducible 14 accelerates pulmonary fibrosis by inducing fibroblast senescence in mice

    by Xin-Xin Guan, Wen-Jing Zhong, Wei-Feng Tang, Yu-Biao Liu, Meng-Rui Chen, Jun-Lan Li, Chen-Yu Zhang, Yong Zhou, Cha-Xiang Guan, Jing-Ni Wu, et al.

    Pulmonary fibrosis (PF) is a chronic and fatal aging-related pulmonary disease. Emerging evidence suggest that fibroblast senescence plays a pivotal role in the initiation and progression of PF. Senescent fibroblasts accumulate in fibrotic lungs, driving excessive extracellular matrix (ECM) deposition, which disrupts tissue architecture and compromises pulmonary function. Notably, senolytic therapy targeting these senescent fibroblasts has shown significant efficacy in ameliorating PF. Therefore, elucidating the mechanisms underlying fibroblast senescence is a promising approach to prevent PF. Herein, our results identify fibroblast growth factor-inducible 14 (Fn14) as a critical mediator in the senescence of fibroblasts. We found that Fn14 was up-regulated in pulmonary fibroblasts from both PF patients and bleomycin (BLM)-treated mice. While knockdown of Fn14 attenuated pulmonary structural disruption and reduced fibroblast senescence in the lung of BLM-treated mice. In vitro , Fn14 activation promoted cellular senescence in pulmonary fibroblasts. Mechanistically, Fn14-induced mitophagy impairment resulted in mitochondrial DNA (mtDNA) leakage, which subsequently activated the cGAS-STING signaling. Moreover, restoring mitophagy or inhibiting cGAS ameliorated fibroblast senescence induced by Fn14 activation. Collectively, these results provide comprehensive insight into the pro-fibrotic role of Fn14 in the development of PF by inducing fibroblast senescence and shed light on the Fn14-targeting therapeutics for PF.

  • Open Access

    Cadmium exposure triggers alveolar epithelial cell pyroptosis by inducing mitochondrial oxidative stress and activating the cGAS-STING pathway

    by Chen-Yu Zhang, An-Jun Ou, Ling Jin, Nan-Shi-Yu Yang, Ping Deng, Cha-Xiang Guan, Xiao-Ting Huang, Jia-Xi Duan, Yong Zhou

    Cadmium is a ubiquitous toxic metal and environmental pollutant. More and more studies have shown that cadmium exposure can damage lung function. Alveolar epithelial cells (AECs) are structural cells that maintain the stability of lung function. The injury of AECs is an essential determinant of many lung diseases. In the lung, cadmium accumulation can cause damage to AECs. However, the specific mechanism is still unclear. This study aimed to explore the key mechanism underlying the injury of AECs caused by cadmium exposure. The main modes of death of AECs induced by cadmium exposure were evaluated in vivo and in vitro. Transcriptomic changes of AECs induced by cadmium exposure were analyzed using RNA-sequence. Mitochondrial ROS scavengers (mitoQ), voltage-dependent anion channel 1 (VDAC1) oligomer inhibitor (VBIT4), and cyclic GMP-AMP synthase (cGAS) inhibitor (RU.521) were used to assess whether cadmium exposure triggered pyroptosis of AECs by inducing mitochondrial stress to activate the cGAS-STING-NLRP3 axis. In this study, the expression of pyroptosis-related proteins was significantly up-regulated in the cadmium-exposed AECs, while the expression of apoptosis, necroptosis, and ferroptosis-related proteins had no significant up-regulated. The pan-caspase inhibitor ZVAD-FMK significantly reduced cell death. Thus, our research indicates that pyroptosis is the primary type of AEC death exported to cadmium. Mechanistically, RNA-seq and Western Blot results showed that cadmium exposure activated the cGAS-STING pathway in AECs and promoted pyroptosis by activating the NLRP3 inflammasome. Further investigation of the mechanism found that cadmium exposure caused mitochondrial oxidative stress, which led to mtDNA leakage into the cytoplasm and activated the cGAS-STING pathway. In addition, inhibition of the cGAS-STING pathway significantly alleviated lung injury induced by cadmium exposure in mice. Our study confirmed that pyroptosis of AECs was a vital mechanism of lung injury after cadmium exposure in a cGAS-STING-dependent manner, which may provide a new target for the treatment of lung diseases induced by cadmium exposure.


  • Open Access

    Epoxyeicosatrienoic acids alleviate alveolar epithelial cell senescence by inhibiting mitophagy through NOX4/Nrf2 pathway

    by Jie-Ru Hong, Chen-Yu Zhang, Wen-Jing Zhong, Hui-Hui Yang, Jian‑Bing Xiong, Ping Deng, Nan-Shi-Yu Yang, Hui Chen, Ling Jin, Cha-Xiang Guan, et al.